Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Activation of Peroxisome Proliferator–Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury

Yue, Tian-li, Bao, Weike, Jucker, Beat M., Gu, Juan-li, Romanic, Anne M., Brown, Peter J., Cui, Jianqi, Thudium, Douglas T., Boyce, Rogely, Burns-Kurtis, Cynthia L., Mirabile, Rosanna C., Aravindhan, Karpagam, Ohlstein, Eliot H. · 2003 · Circulation

Abstract

Background— Peroxisome proliferator–activated receptor-α (PPAR-α) is expressed in the heart and regulates genes involved in myocardial fatty acid oxidation (FAO). The role of PPAR-α in acute ischemia/reperfusion myocardial injury remains unclear. Methods and Results— The coronary arteries of male mice were ligated for 30 minutes. After reperfusion for 24 hours, ischemic and infarct sizes were determined. A highly selective and potent PPAR-α agonist, GW7647, was administered by mouth for 2 days, and the third dose was given 1 hour before ischemia. GW7647 at 1 and 3 mg · kg −1 · d −1 reduced infarct size by 28% and 35%, respectively ( P <0.01), and myocardial contractile dysfunction was also improved. Cardioprotection by GW7647 was completely abolished in PPAR-α–null mice. Ischemia/reperfusion downregulated mRNA expression of cardiac PPAR-α and FAO enzyme genes, decreased myocardial FAO enzyme activity and in vivo cardiac fat oxidation, and increased serum levels of free fatty acids. All of these changes were reversed by GW7647. Moreover, GW7647 attenuated ischemia/reperfusion-induced release of multiple proinflammatory cytokines and inhibited neutrophil accumulation and myocardial expression of matrix metalloproteinases-9 and -2. Furthermore, GW7647 inhibited nuclear factor-κB activation in the heart, accompanied by enhanced levels of inhibitor-κBα. Conclusions— Activation of PPAR-α protected the heart from reperfusion injury. This cardioprotection might be mediated through metabolic and antiinflammatory mechanisms. This novel effect of the PPAR-α agonist could provide an added benefit to patients treated with PPAR-α activators for dyslipidemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000093187.42015.6c

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 189

Metadata

Authors
Yue, T.-L., Bao, W., Jucker, B. M., Gu, J.-L., Romanic, A. M., Brown, P. J., Cui, J., Thudium, D. T., Boyce, R., Burns-Kurtis, C. L., Mirabile, R. C., Aravindhan, K., & Ohlstein, E. H.
Venue
Circulation
Published
2003-11-11
Volume
108
Issue
19
Pages
2393-2399
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2033860536
Cited by
189
References
4
FWCI
6.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of Peroxisome Proliferator–Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury. https://app.cochat.ai/papers/10.1161/01.cir.0000093187.42015.6c
The paper
Yue, T.-L., Bao, W., Jucker, B. M., Gu, J.-L., Romanic, A. M., Brown, P. J., Cui, J., Thudium, D. T., Boyce, R., Burns-Kurtis, C. L., Mirabile, R. C., Aravindhan, K., & Ohlstein, E. H. (2003). Activation of Peroxisome Proliferator–Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury. Circulation. https://doi.org/10.1161/01.cir.0000093187.42015.6c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.